Category Specific RSS

blood test

Cleo’s ovarian cancer blood test proves more effective than CA125 clinical benchmark and ultrasound

A benchmarking study comparing ovarian cancer diagnostics company Cleo Diagnostics (ASX: COV)’s blood test against ultrasound has been published in…

1 year ago

Syntara doses first blood cancer patient for combination treatment of SNT-5505 and ruxolitinib

Clinical stage drug development company Syntara (ASX:SNT) is set to get a big boost in exposure within the blood cancer…

2 years ago

IPO Watch: Cleo Diagnostics to go public with ovarian cancer test kits to address 51% survival rate

As diseases continue to adapt, the realm of medical diagnostics must intelligently progress to adeptly combat these changes. Timely interventions…

2 years ago

Atomo Diagnostics expands HIV self-test kits to South Africa as HIV rate hikes

Ranked fourth among countries with the highest HIV prevalence in the world, there were about 7.5 million people living with…

2 years ago

Theranos, but make it legit.. Does this company have the answer to cancer detection via blood test?

Treating cancer is a primary goal of many biotech companies, but for any treatment to begin, physicians need a definitive…

3 years ago

Study results emerge for Proteomics International Laboratories’ latest cancer diagnostic test

Your Friday crash course: Diagnostic biomarkers are in essence, used to determine whether or not a patient has a medical…

4 years ago